Home
ICON Views
Emerging Markets
Investigators
Contact
SERVICES
THERAPEUTICS
TECHNOLOGY
INVESTORS
NEWS & EVENTS
CAREERS
News
Events
Mediakit
Thought Leadership
Video
Insight Newsletter
Awards
ICON plc - Clinical Research Organisation (CRO) for Drug Development »
News & Events »
News »
Sunesis Pharmaceuticals selects ICON as clinical trial partner for its pivotal Phase III trial
Sunesis Pharmaceuticals selects ICON as clinical trial partner for its pivotal Phase III trial
Click here to read full release>>
